Diabetes and artificial intelligence beyond the closed loop: a review of the landscape, promise and challenges.

ABSTRACT: The discourse amongst diabetes specialists and academics regarding technology and artificial intelligence (AI) typically centres around the 10% of people with diabetes who have type 1 diabetes, focusing on glucose sensors, insulin pumps and, increasingly, closed-loop systems. This focus is reflected in conference topics, strategy documents, technology appraisals and funding streams. What is often overlooked is the wider application of data and AI, as demonstrated through published literature and emerging marketplace products, that offers promising avenues for enhanced clinical care, health-service efficiency and cost-effectiveness. This review provides an overview of AI techniques and explores the use and potential of AI and data-driven systems in a broad context, covering all diabetes typ

SUBMITTER: Mackenzie SC 

PROVIDER: S-EPMC10789841 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature